unknown
Stage
4
Investors
About
Themis Bioscience is a biotechnology company that develops viral-vector vaccine platforms and vaccine candidates for infectious diseases. It focuses on advancing vaccines from preclinical stages into clinical trials using its live-attenuated/viral vector technology.
Explore Themis Bioscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.